While rare, some users report changes in mood or emotional sensitivity
Bimagrumab This investigational medication (also not yet approved by the FDA) by Eli Lilly works by targeting activin type II receptors, which reduce fat while increasing muscle
Medicaid coverage for weight loss medications, including GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), varies dramatically from state to sta
An FDA-Approved Oral GLP-1 for Weight Loss Foundayo, also known by its generic name orforglipron, is an FDA-approved oral GLP-1 receptor agonist designed to assist adults in weight loss and management
AI-Powered Support: Combines expert medical knowledge with personalized care
The absence of clear evidence connecting particular changes in the microbiome to cardiovascular disease is one of the main drawbacks of current research